These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19295331)

  • 1. Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort.
    Madec Y; Boufassa F; Avettand-Fenoel V; Hendou S; Melard A; Boucherit S; Surzyn J; Meyer L; Rouzioux C;
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):19-26. PubMed ID: 19295331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.
    Grabar S; Selinger-Leneman H; Abgrall S; Pialoux G; Weiss L; Costagliola D
    PLoS One; 2017; 12(10):e0184441. PubMed ID: 28968404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
    Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
    J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.
    Grabar S; Selinger-Leneman H; Abgrall S; Pialoux G; Weiss L; Costagliola D
    AIDS; 2009 Jun; 23(9):1163-9. PubMed ID: 19444075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors.
    Broström C; Visco-Comandini U; Yun Z; Sönnerborg A
    J Infect Dis; 1999 Jun; 179(6):1542-8. PubMed ID: 10228079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
    Rouzioux C; Hubert JB; Burgard M; Deveau C; Goujard C; Bary M; Séréni D; Viard JP; Delfraissy JF; Meyer L;
    J Infect Dis; 2005 Jul; 192(1):46-55. PubMed ID: 15942893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early CD4 T-cell count in HIV-1 seroconverters in Côte d'Ivoire and France: the ANRS PRIMO-CI and SEROCO cohorts.
    Lewden C; Thiébaut R; Boufassa F; Coulibaly A; Malateste K; Seng R; Toni TD; Inwoley A; Rouzioux C; Minga A; Anglaret X; Meyer L
    J Acquir Immune Defic Syndr; 2010 Feb; 53(2):260-5. PubMed ID: 19745754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
    Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
    J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
    HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Factor Predictors in Long-term Nonprogressors HIV-1 Infected with Distinct Viral Clades.
    Dos Santos JS; de Almeida SM; Ferreira GS; Bordignon J; Maia Teixeira SL; Martins Lima AC; Raboni SM
    Curr HIV Res; 2017; 15(6):440-447. PubMed ID: 29210660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.
    Ghosn J; Deveau C; Chaix ML; Goujard C; Galimand J; Zitoun Y; Allègre T; Delfraissy JF; Meyer L; Rouzioux C;
    J Antimicrob Chemother; 2010 Apr; 65(4):741-8. PubMed ID: 20167586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults.
    Minga AK; Anglaret X; d' Aquin Toni T; Chaix ML; Dohoun L; Abo Y; Coulibaly A; Duvignac J; Gabillard D; Rouet F; Rouzioux C
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):350-4. PubMed ID: 18545149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
    Demeter LM; Hughes MD; Coombs RW; Jackson JB; Grimes JM; Bosch RJ; Fiscus SA; Spector SA; Squires KE; Fischl MA; Hammer SM
    Ann Intern Med; 2001 Dec; 135(11):954-64. PubMed ID: 11730396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
    Frange P; Faye A; Avettand-Fenoël V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; Sáez-Cirión A;
    Lancet HIV; 2016 Jan; 3(1):e49-54. PubMed ID: 26762993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elite controllers long-term non progressors present improved survival and slower disease progression.
    Capa L; Ayala-Suárez R; De La Torre Tarazona HE; González-García J; Del Romero J; Alcamí J; Díez-Fuertes F
    Sci Rep; 2022 Sep; 12(1):16356. PubMed ID: 36175445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda.
    Laeyendecker O; Redd AD; Lutalo T; Gray RH; Wawer M; Ssempijja V; Gamiel J; Bwanika JB; Makumbi F; Nalugoda F; Opendi P; Kigozi G; Ndyanabo A; Iga B; Kiwanuka N; Sewankambo N; Reynolds SJ; Serwadda D; Quinn TC
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):316-9. PubMed ID: 19726998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.
    Andreoni M; Parisi SG; Sarmati L; Nicastri E; Ercoli L; Mancino G; Sotgiu G; Mannazzu M; Trevenzoli M; Tridente G; Concia E; Aceti A
    AIDS; 2000 Jan; 14(1):23-9. PubMed ID: 10714564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.
    Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivière Y; Warszawski J; Rouzioux C; Buseyne F
    J Infect Dis; 2012 May; 205(10):1520-8. PubMed ID: 22427678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.